Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Clin Cancer Res. 2023 Nov 1;29(21):4399–4407. doi: 10.1158/1078-0432.CCR-23-1295

Table 2-.

Univariable and Multivariable Analysis of Overall Survival in Patients who Received Chemotherapy

Univariable Multivariable

Characteristic (Reference) HR1 95% CI1 p-value HR1 95% CI1 p-value

Age 1.06 1.04, 1.07 <.001 1.05 1.04, 1.06 <.001
Sex (Male)
 Female 1.11 0.82, 1.49 .49
Race (White)
 Black 0.98 0.40, 2.40 .97
 Other/Unknown 0.99 0.44, 2.23 .97
 Asian/Pacific Islander 0.56 0.18, 1.75 .32
Charlson-Deyo Comorbidity Index (0)
 1 2.01 1.35, 3.00 <.001 1.83 1.22, 2.74 .004
 2 or more 3.11 1.99, 4.86 <.001 2.72 1.71, 4.31 <.001
Grade (2)
 3 3.01 2.09, 4.35 <.001 3.28 2.25, 4.79 <.001
Extent of Resection (No surgery/Subtotal)
 Gross-total resection 0.66 0.48, 0.91 .01 0.63 0.46, 0.88 .006
Radiation (No)
 Yes 1.72 1.08, 2.72 .02 1.31 0.82, 2.08 .26
MGMT (Methylated)
 Unmethylated 2.07 1.51, 2.85 <.001 2.61 1.89, 3.60 <.001
1

HR = Hazard Ratio, CI = Confidence Interval

Bold is statistically significant.